Pharma Aids Limited (DSE:PHARMAID)
Bangladesh · Delayed Price · Currency is BDT 569.50
-7.20 (-1.25%)
At close: Jun 15, 2026
Pharma Aids Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 77.65 | 63.82 | 61.19 | -6.38 | 34.76 | 50.26 |
Depreciation & Amortization | 9.51 | 6.5 | 6.92 | 7.62 | 7.82 | 8.25 |
Other Operating Activities | 0.75 | -4.9 | -4.82 | -6.51 | -3.69 | -4.8 |
Change in Accounts Receivable | -26.28 | -30.73 | 1.63 | -2.54 | 6.21 | 11.85 |
Change in Inventory | 14.1 | 10.81 | -17.47 | 6.5 | -15.18 | -27.67 |
Change in Accounts Payable | 0.31 | -1.67 | 3.89 | 0.24 | 1.25 | -0.26 |
Change in Other Net Operating Assets | -13.14 | -4.07 | -28.55 | 8.33 | 2.67 | -6.22 |
Operating Cash Flow | 62.91 | 39.76 | 22.79 | 7.27 | 33.85 | 31.41 |
Operating Cash Flow Growth | 27438.32% | 74.49% | 213.55% | -78.53% | 7.77% | -22.82% |
Capital Expenditures | -56.17 | -57.13 | -0.18 | -2.21 | -4.7 | -10.28 |
Sale of Property, Plant & Equipment | 0.02 | 0.55 | - | - | - | - |
Sale (Purchase) of Real Estate | -0.58 | -13.53 | - | - | - | - |
Other Investing Activities | - | - | 0.11 | 0.2 | 0.37 | 4.6 |
Investing Cash Flow | -56.73 | -70.12 | -0.07 | -2.01 | -4.33 | -5.68 |
Short-Term Debt Issued | - | 16.49 | - | 0.49 | 0.68 | - |
Total Debt Issued | -0.33 | 16.49 | - | 0.49 | 0.68 | - |
Short-Term Debt Repaid | - | - | -0.28 | - | - | -4.78 |
Total Debt Repaid | - | - | -0.28 | - | - | -4.78 |
Net Debt Issued (Repaid) | -0.33 | 16.49 | -0.28 | 0.49 | 0.68 | -4.78 |
Common Dividends Paid | -9.7 | -7.66 | -4.83 | -15.54 | -25.27 | -15.05 |
Financing Cash Flow | -10.02 | 8.83 | -5.11 | -15.05 | -24.59 | -19.83 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - |
Net Cash Flow | -3.84 | -21.53 | 17.61 | -9.79 | 4.93 | 5.89 |
Free Cash Flow | 6.74 | -17.37 | 22.6 | 5.06 | 29.15 | 21.12 |
Free Cash Flow Growth | - | - | 346.82% | -82.64% | 37.97% | -40.81% |
Free Cash Flow Margin | 1.36% | -3.97% | 5.37% | 1.64% | 9.02% | 7.54% |
Free Cash Flow Per Share | 2.16 | -5.57 | 7.25 | 1.62 | 9.34 | 6.77 |
Cash Interest Paid | 0.62 | 1.75 | 0.26 | 0.24 | 0.24 | 0.9 |
Cash Income Tax Paid | 8.73 | 27.15 | 32.43 | 23.71 | 25.15 | 23.17 |
Levered Free Cash Flow | -3.04 | -88.26 | 5.59 | 9.86 | 20.13 | 17.39 |
Unlevered Free Cash Flow | -1.47 | -87.17 | 5.75 | 10.01 | 20.37 | 17.95 |
Change in Working Capital | -25 | -25.66 | -40.5 | 12.54 | -5.05 | -22.3 |